In the closing days of the session just before the August
recess, the United States Senate considered and rejected four major
proposals to provide prescription drug coverage for Medicare
beneficiaries. Does this mean the end of the Medicare drug debate
for this session?
Joseph Antos of the American Enterprise Institute, a former
Assistant Director of the Congressional Budget Office, who analyzed
various Medicare proposals in Congress, and Grace Marie Turner,
President of the Galen Institute, have carefully developed a major
proposal that could yet break the logjam in the Senate. Their
"Prescription Drug Security Plan" would combine a generous, up-
front federal subsidy for routine drug expenses with back-end
catastrophic coverage for high drug costs.
The Plan would target federal subsidies to low and moderate
income seniors who do not have access to drug coverage. But,
because the plan is voluntary, it would be open to all Medicare
More About the Speakers
Joseph Antos Ph.D.
Resident Scholar, The American Enterprise Institute
President, Galen Institute
Robert E. Moffit, Ph.D.